Detalhe da pesquisa
1.
Update and European consensus on a patient-centered core outcome set for multiple myeloma in clinical practice and research.
Haematologica
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299690
2.
Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial.
Haematologica
; 104(11): 2265-2273, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30948492
3.
Treatment emergent peripheral neuropathy in the CASSIOPEIA trial.
Haematologica
; 107(7): 1726-1730, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35295081
4.
Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer Registry.
Hemasphere
; 6(2): e683, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106452
5.
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project.
J Clin Oncol
; 40(29): 3406-3418, 2022 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605179
6.
Innovations in treatment and response evaluation in multiple myeloma.
Haematologica
; 101(5): 518-20, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27132277
7.
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma.
J Clin Oncol
; 39(32): 3613-3622, 2021 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34520219
8.
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies.
ESMO Open
; 5(1)2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31958292
9.
Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
Liver Int
; 28(2): 264-70, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17927714
10.
Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial.
Hemasphere
; 4(4): e370, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32885140